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Introduction
Heart failure with preserved ejection fraction (HFpEF) is associated with an approximate 30% heart failure readmission rate, 1 significantly impaired quality of life, and 23% mortality over 3 years. 2 Unfortunately, there are no guideline-recommended pharmacologic therapies that improve any of these frequencies.
Exercise intolerance is the hallmark of HFpEF, though the mechanism of this limitation is incompletely understood. Not only have abnormalities in diastolic and systolic function been identified, 3 but evidence exists for peripheral derangements in the arteries and skeletal muscle.
Subjects with HFpEF have impaired exercise vasodilatory reserve 4, 5 and increased late systolic pressure augmentation from arterial wave reflections. 6 Abnormalities of skeletal muscle have also been identified including greater fat deposition, a shift from slow-twitch oxidative fibers to more easily fatigable type-II glycolytic fibers, and reduced capillary-to-fiber ratios. 7, 8 The reduction in blood flow to exercising muscle may lead to greater reliance on anaerobic glycolysis, predisposing to earlier exhaustion.
Historically, endogenous NO generation was thought to occur exclusively by nitric oxide synthases (NOS). More recently, however, the nitrate-nitrite-NO pathway has been recognized as an important alternative source of NO in vivo. After ingestion, nearly 25% of the ingested dose is concentrated within the salivary glands before secretion into the oral cavity where anaerobic bacteria convert nitrate (NO 3 -) to nitrite (NO 2 -). 9, 10 Subsequently, metalloproteins, such as deoxyhemoglobin and deoxymyoglobin, facilitate the reduction of systemically-absorbed NO 2 to NO. 11, 12 Importantly, whereas NO generation by the nitric oxide synthases requires molecular oxygen and may be limited by hypoxia, 10 the conversion of NO 2 - to NO occurs preferentially in the setting of hypoxia, [12] [13] [14] as would be found in exercising muscle. This would be especially true pressure augmentation from arterial wave reflections. 6 Abnormalities of skeletal l m m mus u u cl cl cle e ha ha have ve v also been identified including greater fat deposition, a shift from slow-twitch oxidative fibers to mo more re re e e ea as asil il ily y y fa fa f tiga ga gab bl ble type-II glycolytic fibers, an an nd d d r r reduced capill lar ar a y-to to o-f -f -fi iber ratios. 7, 8 The e edu u uct c ion in b blo lood od od flo low w to to to e e exe xe xer rci cisi si sin ng ng m m mu u uscl le e m m may y y l le ead d d t to o o g gr gre ea ate ter r r r re eli lian an nce e e o on n n a an anae ae ero ro r bi bi bic c c gl glyc yc ycol ol olys ys ysis is, , pr pr pred edi is spo po posi sing ng g to to e ear ar a li li lier er er e e ex xh xhau au aust st stio io ion.
Histor or ric ic ical al a ly ly ly, , en en ndo d d ge ge geno no nous us us N N NO O O ge ge ene ne nera ra ati ti ion on on w w was as as t tho ho ou u ugh gh ght t t to to to o o occ c cur ur ur e e exc xc xclu lu usi siv v vel el ely y y by by by n nitric oxide e e by guest on April 1, 2017 http://circ.ahajournals.org/ Downloaded from for fast-twitch muscles under blood-flow compromised conditions, such as in HFpEF. 15 Therefore inorganic nitrate may be a potent mediator of hypoxic vasodilation, a setting in which the classical NOS-mediated pathway is likely impaired.
Beyond vasodilation, inorganic nitrate has been shown to impact the O 2 -cost of force generation, leading to less oxygen consumed per unit of work performed. [16] [17] [18] [19] The mechanism of this reduction remains incompletely understood, though a mitochondrial effect has been suggested. The putative impact of NO on the mitochondria include preservation of the proton gradient across the mitochondrial membrane, improved oxidative phosphorylation efficiency, a reduction in basal mitochondrial energy needs, reduced ATP cost for force generation, and a reduction in uncoupling proteins. 18, 20, 21 In this trial, we tested the hypothesis that inorganic nitrate administration improves exercise capacity in HFpEF. We also investigated the effect of inorganic nitrate on the vasculature and skeletal muscle to obtain insight into the mechanisms through which an effect on exercise tolerance may occur. 18, 20, 21 In this trial, we tested the hypothesis that inorganic nitrate administration improves ex xer er erci ci cis se se c c cap ap apa a acit ty y y i in in HFpEF. We also investigated ed ed t th he effect of ino no organ an nic ic ic nitrate on the 
Methods

Inclusion/Exclusion Criteria
Study Design
This was a randomized double-blind cross-over study of a single dose of inorganic nitrate given in the form of concentrated nitrate-rich beetroot juice (NO 3 -, BEET IT Sport, James White Drinks Ltd., Ipswich, UK) containing 12.9 mmoles of NO 3 in 140 mL versus an otherwise identical nitrate-depleted placebo (PB, James White Drinks, LTD., Ipswich, UK) given 3 hours before maximal-effort cardiopulmonary exercise testing. After completion of the initial visit and all study procedures (Figure 1) , subjects underwent a washout period of at least 5 days before crossing over to the other arm (mean 11.8 days, range 5-42 days).
We tested the hypothesis that inorganic nitrate supplementation would increase exercise capacity in HFpEF and assessed key peripheral mechanisms of this effect. Specifically, we assessed whether inorganic nitrate increases: (1) Our primary outcome of exercise efficiency (the ratio of total work performed to total oxygen consumed); and secondary outcomes which include evascularized; or any condition which the investigators felt could compromise th th he su s s bj bj bjec ec ect' t' t s s s ability to participate in the study or exercise safely. 
St tud ud udy y y De De Desi si sign gn gn
Study Procedures
Subjects took all regularly prescribed medications on their schedule. Subjects were asked to refrain from using mouthwash on study days, as alterations in the oral flora impact nitrate metabolism. 28 Subjects were also asked to avoid phosphodiesterase-5 inhibitors for at least two days prior to avoid any interaction with nitrate. Blood pressure was taken in the right arm with a validated oscillometric device (Omron HEM-705CP, Omron Corporation, Kyoto, Japan) after 5 minutes of rest. Subjects were then given 140 mL of nitrate-rich beetroot juice (NO 3 -) or placebo (PB). Blood pressure was taken every 10 minutes for the next 2 hours using the same oscillometric device. After 2 hours, venipuncture was performed, and blood was centrifuged at 3000 RPM for 5 minutes before storage at -80°C. NT-pro-BNP levels were measured in a batch at the end of the study (Orthoclinical Diagnostic Vitros 3600; upper limit of normal: 124 pg/mL).
Resting echocardiography and arterial hemodynamics at rest
A standard transthoracic echocardiogram was performed using a Vivid 7 machine (General Electric, Fairfield, CT) in accordance with American Society for Echocardiography recommendations. 22, 29 Special attention was given to obtaining adequate left-ventricular outflow Subjects took all regularly prescribed medications on their schedule. Subjects w wer e ere as a ke ke ked d d to to to efrain from using mouthwash on study days, as alterations in the oral flora impact nitrate me meta ta tabo bo boli li lism m sm. 28 28 2 S Sub ub ubj je jects were also asked to avoid d d p p ph hosphodiestera ase se s -5 i i in n nh hi hibitors for at least two d da day ys ys prior to av avo oi o d d d an any y in in inte te tera ra ac ct ctio ion n n w w wit th h n nitra a ate e e. Blo loo od p p pr re ress ss su ur re e wa wa was ta tak ke k n n n in in n t t th he he r rig ig i ht ht 
Maximal Effort Cardiopulmonary Exercise Test
We used a supine cycle ergometer designed for stress echocardiography (Stress Echo Ergometer 1505, Medical Positioning, Inc., Kansas City, MO). Subjects underwent expired gas analysis using a ParvoMedics True One 2400 device (Parvomedics, Utah, USA). Subjects performed a maximal exertion-limited exercise test using a graded-exercise protocol. Resistance began at 12.5 Watts (W) for 3 minutes, increasing to 25W for 3 minutes, then increasing by 25W every 3 minutes thereafter. 30 Breath-by-breath information was recorded. Oscillometric blood pressure, heart rate, and oxygen saturation were monitored during the test using a patient monitor Doppler LVOT VTI was acquired at peak exertion immediately at the cessation of exercise.
Custom-designed software was programmed in MATLAB (Version R2011b, MathWorks, Natick, MA) for processing and quantification of CPET data. All data quantification was blinded to treatment (NO 3 vs. PB). Breath-by breath CPET data was visually assessed, and aberrant breaths were excluded. A Savitzky-Golay filter was then used to remove high-frequency breath-by-breath noise in an operator-independent manner. Peak oxygen uptake (VO 2 ) was determined as the average value during the final 30 seconds of exercise. The gas exchange/ventilatory threshold (VT) was determined using both the V-slope and ventilatory equivalent methods, with the results of the two measurements averaged. 31 V E /VCO 2 slope was calculated from the beginning of exercise to peak effort. 32 Respiratory exchange ratio (RER) was calculated as the ratio of VCO 2 to VO 2 at end-exercise. Arterial tonometry data was analyzed using SphygmoCor software (AtCor Medical, Australia).
Assessment of skeletal muscle oxygenation during exercise
We measured skeletal muscle oxygenation continuously during exercise using near-infrared spectroscopy (NIRS). In brief, the NIRS device emits two wavelengths (760 nm and 850 nm) of light corresponding to peaks in the absorption spectra of deoxyhemoglobin and oxyhemoglobin, respectively. The device measures the intensity of the transmitted and received light, with the absorbed fraction being a measure of the respective hemoglobin concentration. This allows for quantification of relative oxyhemoglobin and deoxyhemoglobin concentrations, with their sum being equal to the total hemoglobin concentration. Tissue Saturation Index (TSI), the ratio of oxyhemoglobin to total hemoglobin concentrations, was automatically calculated. The NIRS exchange/ventilatory threshold (VT) was determined using both the V-slope and d ve ve en nt n il il ilat at ator or ory y y equivalent methods, with the results of the two measurements averaged. 31 V E /VCO 2 slope was ca alc lc cul ul ulat at ated ed ed f f fro ro om th th the e e beginning of exercise to peak ak ak e ef ffort. 32 Subcutaneous fat thickness at the site of NIRS interrogation was measured with ultrasound to assure that skeletal muscle was being interrogated. Figure 2 provides a summary of the physiologic signals obtained during maximal-effort exercise testing.
Constant-Intensity Protocol Cardiopulmonary Exercise Test
Approximately 15 minutes after the maximal exertion test, subjects were again connected to the CPET circuit and underwent a 6-minute protocol at a constant 25W-resistance. Care was taken to ensure that the vital signs and RER returned to baseline prior to beginning the next exercise session. Steady-state VO 2 was defined as the average VO 2 during the final 60 seconds of exercise. 32
Skeletal muscle mitochondrial oxidative function and post-occlusive hyperemia
We performed skeletal muscle mitochondrial function testing using the technique developed by 
Post-occlusive reactive hyperemia
A minimum of five minutes passed, after which baseline brachial artery diameter and flow velocities in the dominant arm were obtained using Doppler ultrasound with a dedicated vascular probe. The brachial cuff was then inflated for 5 minutes to suprasystolic pressures at 200 mm Hg. After cuff release, brachial artery diameter and velocities were obtained at 1-minute to compute volume flow (product of VTI x brachial artery cross-sectional area).
Plasma measurements
Plasma levels of nitric oxide-metabolites (NO x, primarily nitrate, nitrite, NO-metal complexes, and low-molecular-weight and protein cysteine-NO adducts) were measured in a batch at the end of the trial, using the method described by Lundberg and Govoni. 9 In brief, samples were first chemiluminescence reaction with ozone (Nitric Oxide Analyzer; Sievers Instruments, Boulder, CO). Signal peaks (mV) were manually integrated, and the corresponding areas were used for the quantification of NO x concentration. To this end, authentic nitrate in the range of 0 to 50 uM was injected, and a ten-point standard curve was constructed by plotting area against nitrate content.
The detection limit of the assay was 1.6 M of nitrate.
Statistical analysis
Endpoints between the NO 3 and PB measurements were compared using the paired t-test for normally-distributed data or the Wilcoxon signed-rank test for non-normally distributed data. A P-value < 0.05 was considered significant. Given the cross-over design, we pre-specified a modified intent-to-treat analysis, which included only subjects who completed both visits. Our study has 80% power to detect standardized differences 0.72 between the PB and NO 3 groups, at a nominal alpha level of 0.05. All analyses were performed using STATA 13.1 (StataCorp, College Station, TX).
Results
A total of 162 subjects were screened, with 20 subjects entering the study (Figure 3) . One subject was found to be in atrial fibrillation during the initial echocardiogram and therefore did not undergo any further procedures. Two subjects did not return for the second visit. Thus, seventeen subjects were included in the final modified intention-to-treat analysis.
Study Participants
The mean age of study participants was 65. Table 1) .
Serum NO x was significantly greater after NO 3 - 
Exercise efficiency and capacity (CPET)
As shown in 
Arterial hemodynamics
Inorganic nitrate supplementation significantly enhanced the reduction in systemic vascular resistance (SVR) at peak exercise ( 
Skeletal muscle oxygenation during exercise
There was no difference in the change in TSI during exercise between groups (P=0.55).
However, the percent change in oxyhemoglobin from baseline to its minimum during exercise tended to be less following NO 3 - P=0.07).
Constant-intensity exercise protocol
Steady-state VO 2 was no different after NO 3 supplementation ( 
Dynamic exercise protocol and post-ischemia hyperemic flow
Resting mVO 2 , measured using NIRS, was not different between the NO 3 and PB arms ( 
Constant-intensity exercise protocol
St tea ea ady dy dy-s -sta ta tate te te V V VO O 2 2 2 w w was no different after NO 3 sup up ppl ple ementation ( Ta Ta able e 2 
Augmentation index
The aortic augmentation index (derived from radial tonometry) was significantly decreased by NO 3 - P=0.13 ).
Discussion
In this study, we tested the impact of inorganic nitrate on exercise. We did not find any change in efficiency, the primary end-point of the study. We demonstrate, however, that a single dose of inorganic nitrate (12.9 mmol) administered prior to exercise significantly improves peak VO 2 in subjects with HFpEF. This change was accompanied by a significant reduction in systemic vascular resistance and a significant increase in cardiac output at peak exercise, as well as an increase in the VO 2 at which VT occurred. Trends for improvements in skeletal muscle oxidative function and post-ischemic brachial artery flow were also found. Overall, our data suggest that NO 3 improves exercise capacity in HFpEF by improving the peripheral response to exercise and by providing greater O 2 delivery to exercising muscles. Inorganic nitrate also reduced late systolic aortic pressure augmentation, which suggests favorable effects on left ventricular pulsatile load.
In our trial, inorganic nitrate increased peak VO 2 in parallel with total work during a maximal exercise test. In contrast to what has been reported in healthy younger subjects, 16, 17, 19, 36-38 we did not observe an increase in efficiency, modeled as either the ratio of total work n this study, we tested the impact of inorganic nitrate on exercise. We did not f fin in nd d an an a y y y ch ch chan an ange ge in efficiency, the primary end-point of the study. We demonstrate, however, that a single dose of n nor or rga ga gani ni nic c ni ni nitr tr trate e (1 (1 (12. performed to total oxygen consumed or a reduction in the steady-state VO 2 during constantintensity exercise. The reason behind this finding is unknown, although several possibilities exist. First, subjects with HFpEF may be sufficiently different from the young healthy individuals included in previous studies, such that inorganic nitrate may have differential effects on the mitochondria in this patient population. Indeed, in a recent study of healthy older individuals, NO 3 supplementation did not reduce the oxygen-cost of exercise, suggesting that perhaps age, and its consequent changes in mitochondria, may account for the difference. [39] [40] [41] Second, it is possible that subjects with HFpEF have an uncoupling between ATP generation and utilization. In accordance with other studies, we demonstrate a trend towards improvement in oxidative function using NIRS following NO 3 supplementation, suggesting improved ATP production. 20, 21 However, improved efficiency of oxygen consumption for a given workload depends on both the efficiency with which oxygen is converted into ATP as well as the mechanical efficiency of the system to generate force with the ATP generated. 21, 41 Previously, Smith et al. demonstrated abnormal creatine kinase shuttling in HFpEF using MRI and suggested that this finding may limit ATP availability to the myofibrils. 42 Restrictive ATP utilization may thus have limited any changes in efficiency.
We found a significant increase in peak VO 2 after a single dose of NO 3 -, which is highly relevant from the clinical standpoint. We demonstrate greater reduction in systemic vascular resistance following NO 3 -, likely contributing to the observed increase in cardiac output. This is consistent with the vasodilatory role of inorganic nitrate. As exercise capacity in heart failure is often limited by oxygen delivery, the improvement in cardiac output and associated improvement in muscle blood flow, was likely the main contributor to the improved peak VO 2 induced by NO 3 in this study. 15, 43, 44 The improvement in VT following NO 3 supplementation is oxidative function using NIRS following NO 3 supplementation, suggesting imp pro r rove ve v d d d AT AT ATP P P production. 20, 21 However, improved efficiency of oxygen consumption for a given workload de epe pe pend nd nds s on on on b b bo oth h th th the e efficiency with which oxyg g ge e en n i is converted int nt n o AT AT TP P P as well as the m mec ch chanical eff ffic ic icie enc ncy y y of of f t t the he he s s sy ys yste te em m m to to o g g gene er ra at te fo fo or rc ce wi wi with th t th he he A A AT TP P g ge en ne e erat at ted ed ed. 21 also consistent with an increased delivery of oxygen, leading to reduced stimulation of glycolytic pathways, and greater exercise times. 15, 45 Unlike prior exercise intervention studies in HFpEF, where improvements were associated with increases in the systemic arteriovenous oxygen gradient, 46 we did not find an increase in the A-V O 2 difference despite the greater workload. Instead, the increase in peak VO 2 in our study occurred in parallel to an increased cardiac output. Similarly, the absence of a lower local muscle oxyhemoglobin or tissue saturation levels with NO 3 -, despite greater workload and presumably local oxygen utilization, would be consistent with increased muscle blood flow. The greater post-occlusive flow within the brachial artery is similarly consistent with an enhancement of hypoxic vasodilation by inorganic nitrate.
Finally, we observed a reduction in central (aortic) augmentation index, a marker of wave reflections that has been shown to be increased in HFpEF. 6 Late systolic load (from wave reflections) has been associated with increased left ventricular remodeling and diastolic dysfunction in animal experimental models 25, 47 and human studies 27, 48 and has been strongly associated with incident heart failure in humans. 49 Our study must be viewed in the context of its strengths and limitations. Strengths of this study include a comprehensive physiologic assessment of the adaptations to exercise, which quantified changes in the vasculature and skeletal muscle in addition to gas exchange. Our study was small, yet the cross-over design reduced measurement variability and enhanced detection of differences between treatments. Our study was composed primarily of males, limiting its generalizability. Our study showed a trend towards improved mitochondrial oxidative function of hypoxic vasodilation by inorganic nitrate. techniques, such as MRI-spectroscopy, would be desirable to confirm our findings. We studied subjects during supine exercise. It is possible that the values of peak VO 2 may have been different with upright exercise. Additionally, we used echocardiography to measure cardiac output at rest and at peak exercise. This technique is technically challenging and may have limited accuracy; however, our analyses were performed blinded to treatment assignment and demonstrated significant differences between groups. The optimal dose of nitrate supplementation is unknown, and perhaps a larger dose may have led to greater benefit. Finally, we made no adjustments for multiple comparisons in this pilot study, which introduces an increased chance of a type I error. However, the consistency of our findings with our prespecified hypotheses makes it unlikely that our conclusions were reached by chance alone. Our results, demonstrating an improvement in exercise capacity with inorganic nitrate, should be confirmed in a larger study that also investigates the longer-term impact of NO 3 in HFpEF.
Conclusions
A single dose of inorganic nitrate supplementation enhanced peak VO 2 we made no adjustments for multiple comparisons in this pilot study, y y which intr ro od oduc uc u e es s a a an n n ncreased chance of a type I error. However, the consistency of our findings with our prep pec ec cif if ifie ie ied d d hy hy hyp poth hes es eses e makes it unlikely that our co co con nc clusions were e r r reach ch hed ed ed by chance alone. Our e esu u ult l s, demon nst stra ra r t ting ng g a an n n im im impr pr prov ovem em emen ent t i i in ex xe xer rcise e c cap p pac ac cit ity y y w wi with th h ino norg gan an anic c n n nit it tra rate te e, , , sh sh shou ould ld d b be e e co onf nf n ir ir irme me m d d in in in a a l la a arg ge ger r s stu ud udy y th th hat at t a a als ls lso o o i in nv nves es esti ti tiga ga g te te tes s t th the e lo o ong ng nger er er-t -ter er erm m m im im mpa pa pac ct o of f NO NO NO 3 
